Product Information
BIMATOPROST 0.03% EYELASH SOLN is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $26.2742 per ML under NDC 62332051103. Its NADAC has been published 297 times since Jan 27, 2021.
FDA first approved this application on Jan 21, 2020. Its Orange Book therapeutic-equivalence code is AT.
Strength
.3 mg/mL
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332051103
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
BIMATOPROSTApproval Type
Generic (ANDA)
FDA Application
ANDA210515FDA Approved
1/21/2020
TE Code
AT
On Market Since
1/21/2020
Pharmacological Classes
Price Statistics
The NADAC for BIMATOPROST 0.03% EYELASH SOLN has been published 297 times since Jan 27, 2021, and over the history we have for it it has declined 19.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $26.2742 per ML |
|---|---|
| All-time high | $34.6544 (May 12, 2021) |
| All-time low | $9.7099 (Nov 20, 2024) |
| 52-week high | $28.1666 |
| 52-week low | $25.6322 |
| Median price | $28.1666 |
| Average price | $27.9645 |
| Largest weekly change | +68.1% (Dec 18, 2024) |
| Weeks tracked | 297 |
| Tracking since | Jan 27, 2021 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 21% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Alembic Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
bimatoprost market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Prostaglandin Analog class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BIMATOPROST 0.03% EYELASH SOLN?
The current National Average Drug Acquisition Cost (NADAC) for BIMATOPROST 0.03% EYELASH SOLN, manufactured by Alembic Pharmaceuticals Inc., is $26.2742 per ML (NDC 62332051103), effective Sep 30, 2026.
How has the price of BIMATOPROST 0.03% EYELASH SOLN changed over time?
Over the history we have for it, the NADAC for BIMATOPROST 0.03% EYELASH SOLN has declined 19.4%. It has been tracked across 297 weekly CMS publications since Jan 27, 2021.
What are the highest and lowest recorded NADAC prices for BIMATOPROST 0.03% EYELASH SOLN?
Since Jan 27, 2021, the NADAC for BIMATOPROST 0.03% EYELASH SOLN has ranged from a low of $9.7099 (Nov 20, 2024) to a high of $34.6544 (May 12, 2021), with a median of $28.1666 per ML.
Are there cheaper alternatives to BIMATOPROST 0.03% EYELASH SOLN?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BIMATOPROST 0.03% EYELASH SOLN, is $20.6493 per ML — about 21% below BIMATOPROST 0.03% EYELASH SOLN.
Who manufactures BIMATOPROST 0.03% EYELASH SOLN?
BIMATOPROST 0.03% EYELASH SOLN (NDC 62332051103) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.